A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma.
Robert Frank CornellRachid C BazJoshua R RichterAdriana RossiDan T VoglChristine ChenChaim ShustikMariano J AlvarezYao ShenT J UngerOsnat Ben-ShaharHongwei WangErkan BalogluWilliam SenapedisXiwen MaYosef LandesmanXiang BaiJustin BaderHongmei XuTracey MarshallHua ChangChristopher J WalkerJatin ShahSharon ShachamMichael G KauffmanCraig C HofmeisterPublished in: American journal of hematology (2021)